Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders.Psychoneuroendocrinology. 2009; 34: S186-S195
- Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults.JAMA. 2008; 299: 1291-1305
- Gene-stress-epigenetic regulation of FKBP5: Clinical and translational implications.Neuropsychopharmacology. 2016; 41: 261-274
- Associations between self-reported and objectively recorded early life stress, FKBP5 polymorphisms, and depressive symptoms in midlife.Biol Psychiatry. 2016; 80: 869-877
- Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: Results from a 10-year prospective community study.Am J Psychiatry. 2011; 168: 1107-1116
- Validity of adult retrospective reports of adverse childhood experiences: Review of the evidence.J Child Psychol Psychiatry. 2004; 45: 260-273
- Influence of sex and stress exposure across the lifespan on endophenotypes of depression: Focus on behavior, glucocorticoids, and hippocampus.Front Neurosci. 2015; 8: 420
- Associations between the FKBP5 haplotype, exposure to violence and anxiety in females.Psychoneuroendocrinology. 2016; 72: 196-204
- FKBP5 moderation of depressive symptoms in peer victimized, post-institutionalized children.Psychoneuroendocrinology. 2015; 51: 426-430
- Psychiatric symptoms in adolescents: FKBP5 genotype—early life adversity interaction effects.Eur Child Adolesc Psychiatry. 2015; 24: 1473-1483